Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trial

Published:2017-09-22 Issue:6 Volume:35 Page:813-819
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Parikh Anish B.,Kozuch Peter,Rohs Nicholas,Becker Daniel J.,Levy Benjamin P.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/article/10.1007/s10637-017-0511-7/fulltext.html

Reference28 articles.

1. Joshua AM, Zanella V, Bowes B et al (2012) A phase II study of neoadjuvant metformin in prostate carcinoma. AACR Annual meeting 2012, Clinical trials symposium, Chicago

2. Jiralerspong S, Palla SL, Giordano SH et al (2009) Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 27(20):3297–3302

3. Kumar S, Meuter A, Thapa P et al (2013) Metformin intake is associated with better survival in ovarian cancer: a case-control study. Cancer 119(3):555–562

4. Ashinuma H, Takiguchi Y, Kitazono S et al (2012) Antiproliferative action of metformin in human lung cancer cell lines. Oncol Rep 28(1):8–14

5. Memmott RM, Mercado JR, Maier CR et al (2010) Metformin prevents tobacco carcinogen-induced lung tumorigenesis. Cancer Prev Res (Phila) 3(9):1066–1076

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the Potential: Caloric Restriction, Caloric Restriction Mimetics, and Their Impact on Cancer Prevention and Treatment;Metabolites;2024-07-30

2. A Systematic Review of Literatures: To Identify Non-Cancer Drugs Repurposed for Lung Cancer;2023-12-04

3. Chemoresistance Mechanisms in Non-Small Cell Lung Cancer—Opportunities for Drug Repurposing;Applied Biochemistry and Biotechnology;2023-09-18

4. Correlations between Demographic, Clinical, and Paraclinical Variables and Outcomes in Patients with KRAS-Mutant or KRAS Wild-Type Metastatic Colorectal Cancer—A Retrospective Study from a Tertiary-Level Center in Romania;Diagnostics;2023-09-13

5. Current status and frontier tracking of clinical trials on Metformin for cancer treatment;Journal of Cancer Research and Clinical Oncology;2023-09-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3